Prostate Cancer - Results from #21420

MRI-compatible positioning device for guiding a focused ultrasound system for transrectal treatment of prostate cancer - Abstract January 17, 2014

Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer - Abstract January 17, 2014

Clinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: A study of a Korean high volume center - Abstract January 17, 2014

Gold seed fiducials in analysis of linear and rotational displacement of the prostate bed - Abstract January 16, 2014

Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance - Abstract January 16, 2014

Brachytherapy training: A survey of French radiation oncology residents - Abstract January 16, 2014

Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy - Abstract January 16, 2014

Urinary PCA3 as a predictor for prostate cancer in a cohort of 3073 men undergoing initial prostate biopsy - Abstract January 16, 2014

Satisfaction with information used to choose prostate cancer treatment - Abstract January 16, 2014

Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy - Abstract January 16, 2014

Tumor target volume for focal therapy of prostate cancer: Does multiparametric MRI allow for a reliable estimation? - Abstract January 16, 2014

From palmistry to anthropometry: Can 2nd to 4th digit length (2D:4D) predict the risk of prostate cancer? - Abstract January 16, 2014

First case of F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative (11)C-choline PET/CT: New imaging techniques may expand pioneering approaches - Abstract January 16, 2014

Preclinical and clinical development of DNA vaccines for prostate cancer - Abstract January 16, 2014

Improving outcome of surgical procedures is not possible without adequate quality measurement - Abstract January 16, 2014

Deferred permanent prostate seed brachytherapy does not affect PSA outcome: Results from a large retrospective cohort - Abstract January 16, 2014

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival - Abstract January 16, 2014

Comparison of different fractionation schedules toward a single fraction in high-dose-rate brachytherapy as monotherapy for low-risk prostate cancer using 3-dimensional radiobiological models - Abstract January 16, 2014

Long term rectal function after high-dose prostate cancer radiotherapy: Results from a prospective cohort study - Abstract January 16, 2014

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT) - Abstract January 16, 2014

Page 1072 of 1435